Omada launches GLP-1 Flex Care offering for employers, expanding its metabolic and chronic care portfolio
Omada Health posts first GAAP-profitable quarter, 2025 revenue up 53% to $260M, issues prudent 2026 growth guide
- Revenue grew 53% in 2025 to $260M, far above initial post-IPO expectations.
- Q4 delivered first GAAP net income ($5M) and record 73% adjusted margins, reflecting strong expansion and earlier-than-expected profitability.
- Q4 revenue rose 58% year over year to $76M, per reported financial results.
- Q4 non-GAAP EPS was $0.08, above analyst estimates alongside stronger-than-expected revenue performance.
- Members rose 55% to 886,000, with covered lives exceeding 25M and <10% penetration.
- GLP-1 care track now supports 150k+ members, driving strong cardiometabolic and multi-condition growth.
- Company launched GLP-1 Flex Care offering for employers, expanding its metabolic and chronic care portfolio.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.